Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meleri Jones

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 30, 2018
Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkersBright Nsokolo, Anne Kanunga, Edford Sinkala, et al.
Virology Journal|October 9, 2024
Upregulation of keratin 15 is required for varicella-zoster virus replication in keratinocytes and is attenuated in the live attenuated vOka vaccine strainCristina Tommasi, Ohad Yogev, Michael B Yee, et al.
Gastroenterology|May 13, 2019
Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to SofosbuvirPeter A C Wing, Meleri Jones, Michelle Cheung, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Ebiomedicine|March 4, 2021
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infectionCharlotte Manisty, Thomas Alexander Treibel, Melanie Jensen, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Science Immunology|December 28, 2020
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infectionCatherine J Reynolds, Leo Swadling, Joseph M Gibbons, et al.
Wellcome Open Research|February 5, 2021
Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19João B Augusto, Katia Menacho, Mervyn Andiapen, et al.
Science (New York, N.Y.)|June 14, 2022
Immune boosting by B.1.1.529 <b>(</b>Omicron) depends on previous SARS-CoV-2 exposureCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 30, 2018
Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkersBright Nsokolo, Anne Kanunga, Edford Sinkala, et al.
Virology Journal|October 9, 2024
Upregulation of keratin 15 is required for varicella-zoster virus replication in keratinocytes and is attenuated in the live attenuated vOka vaccine strainCristina Tommasi, Ohad Yogev, Michael B Yee, et al.
Gastroenterology|May 13, 2019
Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to SofosbuvirPeter A C Wing, Meleri Jones, Michelle Cheung, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Ebiomedicine|March 4, 2021
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infectionCharlotte Manisty, Thomas Alexander Treibel, Melanie Jensen, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Science Immunology|December 28, 2020
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infectionCatherine J Reynolds, Leo Swadling, Joseph M Gibbons, et al.
Wellcome Open Research|February 5, 2021
Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19João B Augusto, Katia Menacho, Mervyn Andiapen, et al.
Science (New York, N.Y.)|June 14, 2022
Immune boosting by B.1.1.529 <b>(</b>Omicron) depends on previous SARS-CoV-2 exposureCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.
Pageof 3